Quantcast
Last updated on April 23, 2014 at 15:23 EDT

Latest BioFortis Inc. Stories

2013-09-25 12:28:28

New Leadership Will Implement Labmatrix(TM) Software to Create Next Generation Biobanking Solutions MORRISVILLE, N.C., Sept. 25, 2013 /PRNewswire/ -- GentrisĀ® Corporation (www.gentris.com), a global leader in pharmacogenomics and biorepository solutions, announced today that it has partnered with BioFortis to integrate its Labmatrix(TM) and Qiagram(TM) software into Gentris' laboratory operations. The Labmatrix(TM) and Qiagram(TM) software will provide an advanced platform for...

2012-09-19 02:30:16

COLUMBIA, Md., Sept. 19, 2012 /PRNewswire/ -- BioFortis Inc., a leading software company in the clinical and translational research space, today introduced its Next Generation Biobanking software platform for biomarker-based clinical research. It will help pharmaceutical, government and academic research centers involved in biomarker-based clinical and translational studies to safely and effectively conduct externalized, science-driven collaborative studies. As biomarker-based clinical...

2012-03-14 08:15:00

COLUMBIA, Md., March 14, 2012 /PRNewswire/ -- The PML Consortium, an association of pharmaceutical and biotechnology companies, has recently selected the Labmatrix and Qiagram software environments from BioFortis to share and manage data relating to biospecimens in a collaborative effort to study a serious adverse event. Progressive multifocal leukoencephalopathy (PML) is an often-fatal disease caused by the JC virus in immunocompromised patients. PML has been identified as a known side...

2011-04-13 08:00:00

COLUMBIA, Md., April 13, 2011 /PRNewswire/ -- BioFortis, Inc. today announced the release of Qiagram, a revolutionary software product that empowers its users to easily access, manage, explore, and retrieve relevant information in data-intensive environments. About Qiagram Qiagram is powered by a new type of business intelligence (BI) technology that allows its users to pose detailed, ad hoc questions by simply drawing diagrams in a web-browser interface. As the visual reflection of a...

2011-04-06 07:30:00

COLUMBIA, Md., April 6, 2011 /PRNewswire/ -- The Catalysis Foundation for Health has selected the Labmatrix(TM) scientific database software system to manage its large-scale international tuberculosis (TB) diagnostic biomarker study that is funded by the Bill & Melinda Gates Foundation. The Catalysis Foundation for Health (CFH) is a non-profit organization dedicated to developing and delivering high value diagnostic tests for resource-poor settings. This unique multi-year TB study...

2011-03-23 08:15:00

COLUMBIA, Md., March 23, 2011 /PRNewswire/ -- Dr. Victor Levenson, a radiation oncologist at Rush University Medical Center, Chicago, and his scientific team have recently selected Labmatrix(TM) to manage their biobanking and biomarker research activities at this top-ranking U.S. medical research institution. Labmatrix is a web-accessible collaborative scientific database software developed by BioFortis, Inc. Dr. Levenson and his team discover DNA methylation biomarkers using genome-wide...

2010-08-24 14:00:00

COLUMBIA, Md., Aug. 24 /PRNewswire/ -- Catholic Health Initiatives' (CHI) Institute for Research and Innovation's Center for Translational Research and BioFortis, Inc. have announced a joint strategic partnership to focus on CHI's vision in personalized healthcare initiatives for community hospitals across their system. CHI's Center for Translational Research (CTR) is a clinical R&D and molecular diagnostics laboratory that supports the progressive advancement, commercialization, and...

2009-03-05 08:58:00

Biomedical Informatics Market Leader BioFortis wins another award for its Labmatrix(TM) platform being used by leading pharmaceutical and institutional clients worldwide for translational research, biomarker discovery, biobanking, and clinical research COLUMBIA, Md., March 5 /PRNewswire/ -- BioFortis, Inc., the leading provider of biomedical informatics solutions used by pharmaceutical and institutional clients, today announced it has won the 2009 Molecular Medicine Tri-Conference "Best...